Based in the United States, Eradivir is a startup.
Eradivir develops small molecule therapies using their Bispecific Antigenic immuno-Therapy (BAiT™️) technology to target diseased cells and viruses for immune system clearance, focusing on treatments such as influenza.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.